HSIC Henry Schein, Inc. - Common Stock
NASDAQ · Health Care · SEC EDGAR で表示 ↗ 終値 10月 5, 2026 10-K/10-Q 8月 4, 2026HSIC 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
HSIC 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
バーの粒度は選択した期間に合わせて調整されます。バーの始値/高値/安値/終値を確認するにはチャートにカーソルを合わせてください。
| 権利落ち日 | 分割 | タイプ |
|---|---|---|
| 2019年2月8日 | 51-for-40 | 順 |
| 2017年9月15日 | 2-for-1 | 順 |
| 2005年3月1日 | 2-for-1 | 順 |
Henry Schein, Inc. - Common Stock について Wikipediaからの企業概要
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners.
History
In 1932, Henry Schein, a graduate of Columbia University College of Pharmacy, borrowed $500 and opened a pharmacy in Queens, New York. The company expanded into dental supplies in the 1960s, and by the late 1980s, Henry Schein held approximately 10 percent of the dental-supply market. Marvin Schein, Henry Schein's son, took over management of daily operations in 1971.
In 1978, founder Henry Schein's son Jay Schein became CEO of the company. When Jay Schein died of cancer in 1989, Stanley Bergman took over as CEO. Bergman was born in South Africa and came to New York in 1976, where he became an accountant. In 1980, he joined Henry Schein and was promoted to CFO.
Henry Schein Inc. filed with the U.S. Securities and Exchange Commission in 1995 to sell 6.2 million shares in an initial public offering with William Blair & Company as the lead underwriter. The IPO raised $72.8 million and began trading on the Nasdaq. By 1996, the company was up to $1.4 billion in sales and $29 million in profit under Bergman's leadership. That year, the company made seventeen acquisitions.
In August 1997, Henry Schein Inc. agreed to buy Sullivan Dental Products Inc. for approximately $318 million. The purchase made the company the world's largest distributor of dental equipment and supplies. By that point, Henry Schein had made 16 acquisitions in 1997. Also in 1997, Henry Schein acquired New York-based medical-products distributor Micro BioMedics Inc as well as Dentrix Dental Systems.
Henry Schein announced the acquisition of demedis GmbH and Euro Dental Holding GmbH in June 2004. In November 2009, it was announced that Henry Schein Inc. and Butler Animal Health Supply would be launching joint venture Butler Schein Animal Health, the largest veterinary sales and distribution company in the United States. Butler Schein Animal Health was rebranded as Henry Schein Animal Health in 2013. Between 1989 and 2016, Henry Schein purchased approximately 200 companies. The company's chief executive officer, Stanley Bergman, was announced as Chief Executive Magazine's CEO of the Year in May 2017.
In 2018, the FTC accused Benco Dental, Patterson Companies, and Henry Schein of violating antitrust laws. In October 2019, the FTC's Chief Administrative Law Judge dismissed the claims against Henry Schein while finding that Benco and Patterson violated U.S. antitrust laws.
In February 2019, Henry Schein spun off the company's animal health business and merged it with Vets First Choice to form a new company. The new company is established as Covetrus.
Henry Schein Inc. was one of the six main defendants in lawsuits with state and local governments of the opioid epidemic in the United States. The company was dismissed as a defendant in October 2019 in the bellwether Summit County, Ohio litigation.
In July 2022, Henry Schein acquired Condor Dental, a dental distribution company.
In April 2023, Henry Schein acquired Biotech Dental, a provider of dental implants, clear aligners, and digital dental software, based in Salon-de-Provence, France.
In July 2023, Henry Schein acquired S.I.N Implant System, a major provider of dental implants in Brazil.
On October 14, 2023, Henry Schein reported a major hack into its core systems, which included investor information, and payroll data - amounting to 35 Terabytes of data being exfiltrated from the company. This resulted in its applications and e-commerce site being unavailable for several days.
In July 2025, Henry Schein announced that Stanley Bergman would be stepping down as CEO at the end of 2025, however he will continue to serve as chairman of the board. In January 2026 the company announced Bergman's successor as Frederick Lowery, Executive Vice President and President, Laboratory Products and BioProduction at Thermo Fisher Scientific.
In 2025, Henry Schein ranked 333rd by revenue on the Fortune 500 list and 34th within the healthcare sector.
Operations
Dental
In 1997, Henry Schein acquired Sullivan Dental Products and Dentrix Dental Systems, making it the world's largest distributor of dental equipment and supplies.
Dentrix Ascend, is a cloud-based dental practice management software platform developed by Henry Schein One for dental offices. The software is accessible through a web browser and includes tools of scheduling, billing, patient records, imaging, and practice management.
Henry Schein established the Henry Schein Dental Business Institute in March 2015 to teach owners and operators of dental practices the fundamentals of business. The first class to complete the program graduated in March 2016. Henry Schein also launched the Henry Schein Digital Dentistry Program at Temple University's Maurice H. Kornberg School of Dentistry in 2016.
In May 2016, Henry Schein's entity Dentrix presented the DEXIS software's ability to integrate X-rays into a patient's chart. Zahn Dental, Henry Schein's laboratory supply business, acquired Custom Automated Prosthetics in June 2016. The acquisition enabled Henry Schein to expand its prosthetic offerings.
In August 2019, Henry Schein acquired a majority equity stake in Cliniclands, a distributor serving dental practices throughout Sweden, Denmark, and Norway.
In May 2021, Henry Schein announced it acquired an 80% ownership position in Jarvis Analytics, a software company that develops comprehensive data analytics tools for dental practitioners.
In June 2021, Henry Schein acquired a 70% ownership position in eAssist Dental Solutions (eAssist), the developer of a virtual dental billing outsourcing service.
In August 2022, Henry Schein acquired Midway Dental Supply, a full-service dental distributor serving across the Midwestern United States.
In January 2023, Henry Schein announced its subsidiary, eAssist Dental Solutions (eAssist), acquired a majority interest in Unitas PPO Solutions (Unitas), a service provider that works with dental practices to assess their commercial insurance participation, set competitive fee-for-service rates, and negotiate contracted reimbursement with commercial insurers.
In July 2024, Henry Schein acquired abc dental AG, a full-service dental distributor offering consumables, equipment, and technical service to general practitioners, specialists, and dental laboratories in Switzerland.
Henry Schein One
In July 2018, Henry Schein and Internet Brands completed a joint venture to form Henry Schein One. The new company delivers integrated dental technology to help improve practice management and marketing as well as patient communication. Since the formation, Henry Schein One has included Dentrix, Dentrix Ascend, Dentalplans.com, Demandforce, Sesame Communications, and Officite as part of its portfolio of dental technology products.
In July 2019, Henry Schein One acquired Elite Computer Italia S.r.L. (Elite), a full-service software company that delivers practice management solutions to dental practices in Italy.
In November 2022, Henry Schein One announced a partnership with VideaHealth, a dental AI platform. As a result, Henry Schein One introduced Dentrix Detect AI, an AI-enabled X-Ray analysis tool. The integration with VideaHealth's FDA-cleared computer-assisted detection (CADe) device can help oral health professionals use AI in dental practices.
In December 2023, Henry Schein One was named to Utah Business Magazine's Best Companies to Work For list.
Medical
In November 2014, Henry Schein Medical announced a strategic arrangement with Cardinal Health. Cardinal Health's physician office-sales organization consolidated into Henry Schein Medical.
In March 2019, Henry Schein acquired North American Rescue (NAR), the leading provider of survivability and casualty-care medical products to the defense and public-safety markets.
In January 2021, Henry Schein acquired a majority ownership position in Prism Medical Products, LLC (PRISM), a nationwide provider of specialty home medical supplies with a core competency in advanced wound care products.
In October 2023, Henry Schein acquired Shield Healthcare, Inc., a supplier of homecare medical products delivered directly to patients in their homes.
In April 2024, Henry Schein acquired TriMed, a developer of orthopedic devices for lower extremities (foot and ankle) and upper extremities (hand and wrist).
In January 2025, Henry Schein acquired all of the assets of Acentus, a medical supplier specializing in Continuous Glucose Monitors (CGMs).
Former division
Animal health
Henry Schein has spun off this division in early 2019 produces software that is used in veterinary practices designed to improve communication and data management including the online cloud-based application, Rapport. In February 2016, Henry Schein released Axis-Q, a software application designed to ease the recording and access of veterinary medical records.
Philanthropy
In 1998, Henry Schein's Back to School program was launched; this program provides underserved children with school supplies and has helped over 65,000 students since its foundation.
Since 1999, Henry Schein has held its annual ‘Holiday Cheer for Children’ program, which donates clothing, toys, and gift cards to over 20,000 children and their families throughout the holiday season.
In 2015, the Alpha Omega International Dental Society and Henry Schein Cares partnered to create the Alpha Omega-Henry Schein Cares Holocaust Survivors Oral Health Program, which offers pro bono oral care to Holocaust survivors. Since its inception, the program has provided treatment to over 1,600 individuals in the United States and Canada.
Since 2018, Henry Schein has supported the Special Olympics, in particular its Healthy Athletes program, through essential health care donations.
In April 2023, Henry Schein launched its Practice Green initiative, which seeks to encourage healthcare professionals to transition towards sustainable practices.
Henry Schein has also served as the exclusive product sponsor for the American Dental Association’s Give Kids A Smile Program. Henry Schein has contributed $20 million in oral health care products and more than 40,000 dental kits.
In April 2025, the Science Based Targets initiative (SBTi) approved Henry Schein's near-term and long-term science-based emissions reduction targets, verifying its net-zero science-based target by 2050.
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か?
| 指標 | 5年トレンド | HSIC | 5年平均 | 競合中央値 | 結論 |
|---|---|---|---|---|---|
| P/E (TTM) | 24.65年平均 ≈21.5 | ≈21.5 | 22.9 | 割高 | |
| P/S (TTM) | 0.75年平均 ≈0.8 | ≈0.8 | 0.5 | 割高 | |
| 株価純資産倍率 (MRQ) | 3.05年平均 ≈2.8 | ≈2.8 | · | · | |
| EV / EBITDA (EV/EBITDA) | 10.65年平均 ≈10.4 | ≈10.4 | · | · | |
| 株価FCF倍率 (TTM) | 16.65年平均 ≈18.5 | ≈18.5 | · | · | |
| 株価収益率(P/CF) (TTM) | 13.55年平均 ≈14.8 | ≈14.8 | 14.0 | 適正価格 | |
| EV / Revenue (EV/売上高) | 0.85年平均 ≈0.8 | ≈0.8 | · | · | |
| EV / FCF (EV/FCF) | 17.95年平均 ≈18.9 | ≈18.9 | · | · | |
| 株価純資産倍率(P/TB) (MRQ) | 4.3 | · | · | · | |
| PEG Ratio (PEGレシオ) | ≈8.2 | · | · | · |
同業他社の中央値は、指標ごとに標準化された基準で計算されており、この銘柄に表示されているTTM/MRQ基準と常に一致するとは限りません。
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
| 指標 | 5年トレンド | HSIC | 5年平均 | 競合中央値 | 結論 |
|---|---|---|---|---|---|
| 粗利益率 (TTM) | 31.3%5年平均 ≈30.8% | ≈30.8% | 4.3% | トップクラス | |
| 営業利益率 (TTM) | 5.0%5年平均 ≈5.5% | ≈5.5% | 1.1% | トップクラス | |
| EBITDAマージン (TTM) | 7.4%5年平均 ≈7.5% | ≈7.5% | 1.3% | トップクラス | |
| 税引前利益率 (TTM) | 4.1%5年平均 ≈5.0% | ≈5.0% | 1.0% | トップクラス | |
| 純利益率 (TTM) | 3.0%5年平均 ≈3.8% | ≈3.8% | 0.63% | トップクラス | |
| ROA (TTM) | 3.6%5年平均 ≈5.2% | ≈5.2% | 3.1% | トップクラス | |
| ROE (TTM) | 12.2%5年平均 ≈13.8% | ≈13.8% | -4.6% | トップクラス | |
| ROIC | 12.4%5年平均 ≈14.2% | ≈14.2% | 12.2% | トップクラス |
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
| 指標 | 5年トレンド | HSIC | 5年平均 | 競合中央値 | 結論 |
|---|---|---|---|---|---|
| 負債資本倍率 (MRQ) | 0.35年平均 ≈0.1 | ≈0.1 | 0.3 | 同水準 | |
| 流動比率 (MRQ) | 1.35年平均 ≈1.6 | ≈1.6 | 0.9 | 高流動性 | |
| Quick Ratio (クイックレシオ) | 0.65年平均 ≈0.7 | ≈0.7 | 0.5 | 高流動性 | |
| Interest Coverage (インタレスト・カバレッジ) | 4.45年平均 ≈12.8 | ≈12.8 | 5.9 | 低流動性 |
成長 収益、EPS、純利益の成長率:前年比、3年CAGR、5年CAGR
| 指標 | 5年トレンド | HSIC | 5年平均 | 競合中央値 | 結論 |
|---|---|---|---|---|---|
| Revenue YoY (収益(前年比)) | 4.0%5年平均 ≈5.8% | ≈5.8% | · | · | |
| Revenue CAGR 3Y (収益(3年CAGR)) | 1.4%5年平均 ≈3.0% | ≈3.0% | · | · | |
| Revenue CAGR 5Y (収益(5年CAGR)) | 5.4% | · | · | · | |
| EPS YoY | 7.2%5年平均 ≈6.0% | ≈6.0% | · | · | |
| Net Income YoY (純利益(前年比)) | 2.1%5年平均 ≈2.9% | ≈2.9% | · | · | |
| EPS CAGR 3Y (EPS年平均成長率 3年) | -5.8%5年平均 ≈-4.6% | ≈-4.6% | · | · | |
| EPS CAGR 5Y (EPS年平均成長率 5年) | 3.0% | · | · | · | |
| Net Income CAGR 3Y (純利益年平均成長率 3年) | -9.6%5年平均 ≈-7.8% | ≈-7.8% | · | · | |
| Net Income CAGR 5Y (純利益年平均成長率 5年) | -0.30% | · | · | · |
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
| 指標 | 5年トレンド | HSIC | 5年平均 | 競合中央値 | 結論 |
|---|---|---|---|---|---|
| Asset Turnover (総資産回転率) | 1.25年平均 ≈1.3 | ≈1.3 | 4.5 | 弱い | |
| Inventory Turnover (棚卸資産回転率) | 4.85年平均 ≈4.8 | ≈4.8 | 15.7 | 弱い | |
| Receivables Turnover (売掛金回転率) | 8.45年平均 ≈8.2 | ≈8.2 | 13.1 | 弱い | |
| Revenue / Employee (年間売上高 ÷ 従業員数(yfinanceの報告ヘッドカウント)。派生値 — SEC-XBRLの保存概念ではありません。) | ≈$527.4K | · | · | · |
バリュエーション · ≈ 5年平均 · 業界中央値 · 中央値に対する評価
決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
| 期間 | レポート | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|---|
| 2026年6月30日 | 8月 11, 2026 | $1.27 | $1.26 | 0.67% |
| 2026年3月31日 | 5月 12, 2026 | $1.32 | $1.24 | 6.3% |
| 2025年12月31日 | $1.34 | $1.33 | 1.1% | |
| 2025年9月30日 | $1.38 | $1.30 | 5.8% | |
| 2025年6月30日 | $1.10 | $1.22 | -9.5% | |
| 2025年3月31日 | $1.15 | $1.13 | 1.6% |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | $8.88B | $11.57B | $10.63B | |
| Cost of Revenue | $9.08B | $8.66B | $8.48B | $8.82B | $8.73B | $7.30B | $6.89B | $6.51B | $6.14B | $8.35B | $7.62B | |
| Gross Profit | $4.11B | $4.02B | $3.86B | $3.83B | $3.67B | $2.82B | $3.09B | $2.91B | $2.75B | $3.23B | $3.01B | |
| SG&A Expense | $3.08B | $3.03B | $2.96B | $2.77B | $2.63B | $2.09B | $2.36B | $2.22B | $2.07B | $2.41B | $2.24B | |
| Operating Expenses | · | · | · | · | · | · | · | $2.70B | $2.53B | $2.41B | · | |
| Operating Income | $653M | $621M | $615M | $747M | $852M | $535M | $718M | $601M | $670M | $772M | $734M | |
| Interest Expense | $150M | $131M | $87M | $35M | $27M | $41M | $51M | $76M | $51M | $32M | $26M | |
| Interest Income | $33M | $24M | $17M | $8M | $6M | $10M | $16M | $15M | $12M | $13M | $13M | |
| Other Non-op | $-3M | $-1M | $-3M | $1M | $0 | $-4M | $-3M | $-3M | $-1M | $3M | $-141.0K | |
| Pretax Income | $533M | $513M | $542M | $721M | $831M | $500M | $680M | $537M | $630M | $756M | $721M | |
| Income Tax | $126M | $128M | $120M | $170M | $198M | $95M | $160M | $107M | $309M | $218M | $211M | |
| Net Income | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | $406M | $507M | $479M | |
| EPS (Basic) | $3.29 | $3.07 | $3.18 | $3.95 | $4.51 | $2.83 | $4.70 | $3.51 | $2.59 | $3.14 | $2.89 | |
| EPS (Diluted) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 | $2.82 | $4.65 | $3.49 | $2.57 | $3.10 | $2.85 | |
| Shares (Basic) | 120,813,977 | 126,788,997 | 130,618,990 | 136,064,221 | 140,090,889 | 142,504,193 | 147,817,000 | 152,656,000 | 156,787,000 | 161,641,000 | 165,687,000 | |
| Shares (Diluted) | 121,717,876 | 127,779,228 | 131,748,171 | 137,755,670 | 141,772,781 | 143,403,682 | 149,257,000 | 153,707,000 | 158,208,000 | 163,723,000 | 168,250,000 | |
| EBITDA | $964M | $918M | $863M | $959M | $1.06B | $721M | $903M | $961M | · | $941M | $893M |
貸借対照表
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $156M | $122M | $171M | $117M | $118M | $421M | · | $57M | $158M | $62M | $72M | |
| Receivables | $1.65B | $1.48B | $1.86B | $1.44B | $1.45B | $1.42B | $1.25B | $1.17B | $1.52B | $1.25B | $1.23B | |
| Inventory | $2.00B | $1.81B | $1.81B | $1.96B | $1.86B | $1.51B | $1.43B | $1.42B | $1.93B | $1.67B | $1.51B | |
| Prepaid Expense | $655M | $569M | $639M | $466M | $413M | $433M | $445M | $451M | $455M | $361M | $361M | |
| Current Assets | $4.46B | $3.98B | $4.49B | $3.99B | $3.84B | $3.79B | $3.23B | $4.18B | $4.09B | $3.34B | $3.23B | |
| PP&E (Net) | · | · | · | · | $366M | $342M | $330M | $314M | $375M | $334M | $318M | |
| PP&E (Gross) | $1.38B | $1.20B | $1.17B | $956M | $916M | $868M | $799M | $905M | $990M | $865M | $797M | |
| Accum. Depreciation | $759M | $670M | $672M | $573M | $550M | $526M | $469M | $591M | $615M | $531M | $478M | |
| Goodwill | $4.21B | $3.89B | $3.88B | $2.89B | $2.85B | $2.50B | $2.46B | $2.08B | $1.55B | $2.02B | $1.91B | |
| Intangibles | $1.02B | $1.02B | $916M | $587M | $668M | $479M | $573M | $376M | $670M | $621M | $593M | |
| Total Assets | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.81B | $6.53B | |
| Accounts Payable | $1.15B | $962M | $1.02B | $1.00B | $1.05B | $1.01B | $880M | $786M | $1.15B | $1.01B | $1.01B | |
| Short-term Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | $951M | · | · | · | |
| Current Liabilities | $3.23B | $2.80B | $2.68B | $2.22B | $2.31B | $2.28B | $2.04B | $3.22B | $2.83B | $2.32B | $2.15B | |
| Capital Leases | $251M | $259M | $310M | $275M | $268M | $239M | $176M | $0 | · | · | · | |
| Deferred Tax | $146M | $102M | $54M | $36M | $42M | $30M | $65M | $27M | $50M | $52M | $253M | |
| Other Non-current Liabilities | $486M | $387M | $436M | $361M | $377M | $393M | $331M | $358M | $420M | $264M | $212M | |
| Total Liabilities | $6.42B | $5.38B | $5.42B | $3.94B | $3.81B | $3.46B | $3.23B | $4.65B | $4.21B | $3.35B | $3.08B | |
| Long-term Debt | · | · | · | $1.05B | $822M | · | · | · | · | · | · | |
| Total Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | · | · | · | · | |
| Paid-in Capital | $177M | $0 | $0 | $0 | $0 | $0 | $48M | $0 | · | · | · | |
| Retained Earnings | $3.29B | $3.77B | $3.86B | $3.68B | $3.60B | $3.45B | $3.12B | $3.21B | $2.94B | $2.98B | $2.90B | |
| AOCI | $-226M | $-379M | $-206M | $-233M | $-171M | $-108M | $-167M | $-249M | $-130M | $-317M | $-220M | |
| Stockholders' Equity | $3.25B | $3.39B | $3.65B | $3.45B | $3.42B | $3.35B | $3.00B | $2.96B | $2.81B | $2.79B | $2.88B | |
| Liabilities + Equity | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.76B | $6.50B | |
| Shares Outstanding | 115,771,149 | 124,155,884 | 129,247,765 | 131,792,817 | 137,145,558 | 142,462,571 | 143,353,459 | 151,401,668 | 153,690,146 | 158,805,010 | 164,830,640 |
キャッシュフロー
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $311M | $297M | $248M | $212M | $210M | $186M | $185M | $144M | $134M | $170M | $159M | |
| Stock-based Comp | $39M | $39M | $39M | $54M | $78M | $9M | $45M | $33M | $37M | $58M | $45M | |
| Deferred Tax | $5M | $-61M | $-20M | $-73M | $-11M | $-53M | $-4M | $-25M | $1M | $-37M | $-6M | |
| Amort. of Intangibles | $180M | $185M | $152M | $126M | $124M | $106M | $108M | $75M | $70M | $98M | $93M | |
| Restructuring | $105M | $110M | $80M | $128M | $8M | · | · | $54M | $0 | $46M | $35M | |
| Other Non-cash | $-41M | $183M | $-183M | $-129M | $-199M | $54M | $-266M | $-54M | · | $-82M | $-90M | |
| Operating Cash Flow | $712M | $848M | $500M | $602M | $710M | $599M | $654M | $685M | $546M | $643M | $616M | |
| CapEx | $139M | $148M | $147M | $96M | $79M | $49M | $76M | $71M | $62M | $70M | $72M | |
| Investing Cash Flow | $-400M | $-430M | $-1.14B | $-276M | $-677M | $-115M | $-424M | $-193M | $-342M | $-316M | $-260M | |
| Debt Issued | $489M | $120M | $1.37B | $270M | $305M | $501M | $741.0K | $115M | $200M | $261M | $135M | |
| Net Debt Issued | $445M | $-198M | $900M | $211M | $183M | $-110M | $-260M | $87M | · | $245M | $-66M | |
| Stock Issued | $250M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $850M | $385M | $250M | $485M | $401M | $74M | $525M | $200M | $450M | $550M | $300M | |
| Net Stock Activity | $-600M | $-385M | $-250M | $-485M | $-401M | $-74M | $-525M | $-200M | · | $-550M | $-300M | |
| Financing Cash Flow | $-188M | $-510M | $701M | $-315M | $-333M | $-187M | $-216M | $-604M | $-113M | $-327M | $-348M | |
| Net Change in Cash | $34M | $-49M | $54M | $-1M | $-303M | $315M | $26M | $-94M | $225M | $-10M | $-17M | |
| Taxes Paid | $128M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $573M | $700M | $353M | $506M | $631M | $550M | $578M | $594M | · | $545M | $515M | |
| Levered FCF | $458M | $602M | $285M | $472M | $610M | $517M | $539M | $533M | · | $523M | $497M |
収益性
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% | 27.8% | 30.9% | 27.2% | · | 28.0% | 28.3% | |
| Operating Margin | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% | 5.3% | 7.2% | 5.7% | · | 6.7% | 6.9% | |
| Net Margin | 3.0% | 3.1% | 3.4% | 4.2% | 5.1% | 4.0% | 7.0% | 4.1% | · | 4.4% | 4.5% | |
| Pretax Margin | 4.0% | 4.0% | 4.4% | 5.7% | 6.7% | 4.9% | 6.8% | 5.3% | · | 6.5% | 6.8% | |
| EBITDA Margin | 7.3% | 7.2% | 7.0% | 7.6% | 8.6% | 7.1% | 9.0% | 7.3% | · | 8.1% | 8.4% | |
| ROA | 3.7% | 3.8% | 4.3% | 6.3% | 7.8% | 5.4% | 8.9% | 6.6% | · | 7.6% | 7.6% | |
| ROE | 12.0% | 11.1% | 11.7% | 15.7% | 18.6% | 12.7% | 23.3% | 18.6% | · | 17.8% | 16.8% | |
| ROIC | 12.4% | 11.5% | 12.2% | 16.1% | 18.7% | 12.7% | 18.2% | 19.7% | · | 19.7% | 18.0% |
流動性と支払能力
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 | 1.7 | 1.6 | 1.3 | · | 1.4 | 1.5 | |
| Quick Ratio | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | 0.5 | · | 0.6 | 0.6 | |
| Debt / Equity | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | · | |
| Interest Coverage | 4.4 | 4.7 | 7.1 | 17.0 | 30.9 | 12.9 | 14.1 | 9.6 | · | 24.2 | 28.2 |
効率性
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.2 | 1.3 | 1.5 | 1.5 | 1.4 | 1.3 | 1.6 | · | 1.7 | 1.7 | |
| Inventory Turnover | 4.8 | 4.8 | 4.5 | 4.6 | 5.2 | 5.0 | 4.8 | 4.9 | · | 5.3 | 5.4 | |
| Receivables Turnover | 8.4 | 7.6 | 7.5 | 8.7 | 8.6 | 7.6 | 8.3 | 8.4 | · | 9.3 | 9.0 |
1株あたり
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $28.03 | $27.33 | $28.28 | $26.15 | $24.97 | $23.50 | $20.91 | $19.56 | · | $35.18 | $35.00 | |
| Revenue / Share | $108.32 | $99.18 | $93.66 | $91.81 | $87.47 | $70.56 | $66.90 | $85.89 | · | $141.36 | $126.36 | |
| Cash Flow / Share | $5.85 | $6.64 | $3.80 | $4.37 | $5.00 | $4.18 | $4.38 | $4.45 | · | $7.52 | $6.98 | |
| Cash / Share | $1.35 | $0.98 | $1.32 | $0.89 | $0.86 | · | · | $0.53 | · | $0.79 | $0.87 | |
| EPS (TTM) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 | $2.82 | $4.65 | $3.49 | · | $3.10 | $2.85 |
成長率
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.0% | 2.7% | -2.4% | 2.0% | 22.6% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.4% | 0.73% | 6.8% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 7.2% | -3.5% | -19.2% | -12.1% | 57.8% | · | · | · | · | · | · | |
| EPS CAGR 3Y | -5.8% | -11.8% | 3.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 3.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 2.1% | -6.2% | -22.7% | -14.7% | 56.2% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -9.6% | -14.8% | 0.98% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.30% | · | · | · | · | · | · | · | · | · | · |
バリュエーション(TTM)
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | · | $11.57B | $10.63B | |
| Net Income TTM | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | · | $507M | $479M | |
| Market Cap | $8.81B | $8.74B | $9.79B | $10.53B | $10.28B | $9.38B | $9.54B | $9.25B | · | $4.72B | $5.08B | |
| Enterprise Value | $9.42B | $9.27B | $9.88B | $10.51B | $10.21B | · | · | · | · | · | · | |
| P/E | 23.3 | 23.1 | 24.0 | 20.4 | 16.8 | 23.3 | 14.3 | 17.5 | · | 19.2 | 21.6 | |
| P/S | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | 0.9 | 1.0 | 1.0 | · | 0.4 | 0.5 | |
| P/B | 2.7 | 2.6 | 2.7 | 3.1 | 3.0 | 2.8 | 3.2 | 3.1 | · | 1.7 | 1.8 | |
| P / Tangible Book | · | · | · | · | · | 25.7 | · | · | · | · | · | |
| P / Cash Flow | 12.4 | 10.3 | 19.6 | 17.5 | 14.5 | 15.7 | 14.6 | 13.5 | · | 7.7 | 8.7 | |
| P / FCF | 15.4 | 12.5 | 27.7 | 20.8 | 16.3 | 17.0 | 16.5 | 15.6 | · | 8.7 | 9.9 | |
| EV / EBITDA | 9.8 | 10.1 | 11.4 | 11.0 | 9.6 | · | · | · | · | · | · | |
| EV / FCF | 16.4 | 13.2 | 28.0 | 20.8 | 16.2 | · | · | · | · | · | · | |
| EV / Revenue | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | · | · | · | · | · | · | |
| Earnings Yield | 4.3% | 4.3% | 4.2% | 4.9% | 5.9% | 4.3% | 7.0% | 5.7% | · | 5.2% | 4.6% |
損益計算書
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.46B | $3.37B | $3.44B | $3.34B | $3.24B | $3.17B | $3.19B | $3.17B | $3.14B | $3.17B | $3.02B | $3.16B | $3.06B | $3.37B | $3.07B | |
| Cost of Revenue | $2.36B | $2.30B | $2.37B | $2.31B | $2.22B | $2.17B | $2.20B | $2.18B | $2.12B | $2.16B | $2.09B | $2.17B | $2.09B | $2.37B | $2.15B | |
| Gross Profit | $1.10B | $1.07B | $1.06B | $1.03B | $1.02B | $1.00B | $993M | $993M | $1.02B | $1.01B | $924M | $995M | $966M | $999M | $914M | |
| SG&A Expense | $831M | $809M | $808M | $760M | $778M | $738M | $738M | $724M | $781M | $791M | $807M | $725M | $717M | $761M | $648M | |
| Operating Income | $171M | $182M | $163M | $164M | $151M | $175M | $155M | $157M | $159M | $150M | $39M | $200M | $175M | $72M | $211M | |
| Interest Expense | $43M | $39M | $39M | $38M | $38M | $35M | $35M | $34M | $32M | $30M | $29M | $25M | $14M | $12M | $8M | |
| Interest Income | $8M | $7M | $9M | $9M | $9M | $6M | $6M | $7M | $6M | $5M | $5M | $6M | $3M | $3M | $1M | |
| Other Non-op | $1M | $0 | $0 | $-1M | $-1M | $-1M | $0 | $-2M | $-1M | $2M | $-1M | $-2M | $-1M | $0 | $1M | |
| Pretax Income | $137M | $150M | $133M | $134M | $121M | $145M | $126M | $128M | $132M | $127M | $14M | $179M | $163M | $63M | $205M | |
| Income Tax | $34M | $38M | $32M | $28M | $31M | $35M | $31M | $32M | $33M | $32M | $1M | $39M | $39M | $15M | $46M | |
| Net Income | $94M | $107M | $101M | $101M | $86M | $110M | $94M | $99M | $104M | $93M | $18M | $137M | $121M | $47M | $150M | |
| EPS (Basic) | $0.83 | $0.93 | $0.85 | $0.84 | $0.71 | $0.89 | $0.75 | $0.79 | $0.81 | $0.72 | $0.14 | $1.06 | $0.92 | $0.37 | $1.10 | |
| EPS (Diluted) | $0.82 | $0.92 | $0.85 | $0.84 | $0.70 | $0.88 | $0.75 | $0.78 | $0.80 | $0.72 | $0.14 | $1.05 | $0.91 | $0.36 | $1.09 | |
| Shares (Basic) | 113,451,329 | 114,939,640 | · | 120,199,552 | 121,927,867 | 123,776,073 | · | 126,124,715 | 127,784,380 | 128,720,661 | · | 130,388,353 | 131,365,789 | · | 135,608,678 | |
| Shares (Diluted) | 114,390,366 | 116,061,244 | · | 121,036,247 | 122,636,948 | 124,848,221 | · | 127,054,934 | 128,646,506 | 129,769,580 | · | 131,442,135 | 133,039,886 | · | 137,084,049 | |
| EBITDA | $255M | $263M | · | $244M | $151M | $248M | · | $157M | $159M | $223M | · | $200M | $227M | · | $211M |
貸借対照表
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $157M | $138M | $156M | $136M | $145M | $127M | $122M | $126M | $138M | $159M | · | $166M | $126M | · | · | |
| Receivables | $1.76B | $1.72B | $1.65B | $1.74B | $1.65B | $1.58B | $1.48B | $1.66B | $1.56B | $1.64B | $1.86B | $1.57B | $1.47B | $1.44B | $1.51B | |
| Inventory | $2.06B | $2.01B | $2.00B | $1.91B | $1.91B | $1.84B | $1.81B | $1.75B | $1.66B | $1.69B | · | $1.83B | $1.92B | · | $1.82B | |
| Prepaid Expense | $621M | $625M | $655M | $604M | $545M | $490M | $569M | $607M | $587M | $589M | · | $541M | $438M | · | $509M | |
| Current Assets | $4.60B | $4.50B | $4.46B | $4.39B | $4.24B | $4.04B | $3.98B | $4.15B | $3.94B | $4.08B | · | $4.11B | $3.95B | · | $3.96B | |
| PP&E (Gross) | · | · | $1.38B | · | · | · | $1.20B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $759M | · | · | · | $670M | · | · | · | · | · | · | · | · | |
| Goodwill | $4.27B | $4.28B | $4.21B | $4.15B | $4.08B | $3.96B | $3.89B | $3.99B | $3.90B | $3.83B | $3.88B | $3.60B | $2.92B | $2.89B | $2.87B | |
| Intangibles | $965M | $1.01B | $1.02B | $1.05B | $1.04B | $1.03B | $1.02B | $1.10B | $1.08B | $915M | · | $834M | $548M | · | $635M | |
| Total Assets | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Accounts Payable | $1.14B | $1.04B | $1.15B | $1.03B | $918M | $908M | $962M | $1.03B | $867M | $879M | · | $953M | $855M | · | $957M | |
| Short-term Debt | $1.02B | $1.05B | $764M | $913M | $901M | $867M | $650M | $638M | $505M | $264M | · | $12M | $236M | · | $107M | |
| Current Liabilities | $3.49B | $3.30B | $3.23B | $3.15B | $3.01B | $2.92B | $2.80B | $2.93B | $2.55B | $2.33B | · | $2.09B | $2.17B | · | $2.15B | |
| Capital Leases | $275M | $263M | $251M | $264M | $259M | $256M | $259M | $262M | $261M | $266M | · | $314M | $274M | · | $271M | |
| Deferred Tax | $153M | $158M | $146M | $144M | $147M | $135M | $102M | $123M | $115M | $77M | · | $91M | $40M | · | $37M | |
| Other Non-current Liabilities | $442M | $437M | $486M | $487M | $504M | $485M | $387M | $414M | $431M | $423M | · | $396M | $368M | · | $338M | |
| Total Liabilities | $6.66B | $6.48B | $6.42B | $6.20B | $6.01B | $5.76B | $5.38B | $5.63B | $5.25B | $5.11B | · | $4.71B | $3.88B | · | $3.73B | |
| Total Debt | $1.02B | $1.05B | · | $913M | $901M | $867M | · | $638M | $505M | $264M | · | $12M | · | · | $107M | |
| Paid-in Capital | $140M | $167M | $177M | $207M | $186M | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | · | $0 | |
| Retained Earnings | $3.20B | $3.29B | $3.29B | $3.38B | $3.48B | $3.63B | $3.77B | $3.77B | $3.80B | $3.84B | · | $3.90B | $3.68B | · | $3.92B | |
| AOCI | $-184M | $-189M | $-226M | $-222M | $-227M | $-317M | $-379M | $-264M | $-292M | $-239M | $-206M | $-247M | $-213M | $-233M | $-312M | |
| Stockholders' Equity | $3.16B | $3.27B | $3.25B | $3.36B | $3.44B | $3.31B | $3.39B | $3.50B | $3.51B | $3.60B | · | $3.65B | $3.47B | · | $3.61B | |
| Liabilities + Equity | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Shares Outstanding | 111,916,222 | 114,424,682 | 115,771,149 | 118,567,917 | 121,895,045 | 122,243,683 | 124,155,884 | 125,154,194 | 127,080,545 | 128,480,909 | 129,247,765 | 129,935,883 | 131,196,783 | 131,792,817 | 135,258,887 |
キャッシュフロー
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $84M | $81M | $82M | $80M | $76M | $73M | $76M | $74M | $74M | $73M | $68M | $69M | $52M | $52M | $52M | |
| Stock-based Comp | $13M | $3M | $10M | $13M | $11M | $5M | $9M | $10M | $12M | $8M | $1M | $14M | $10M | $10M | $17M | |
| Deferred Tax | $-10M | $2M | $5M | $7M | $0 | $-7M | $-20M | $-22M | $-21M | $2M | $-16M | $-1M | $2M | $-53M | $-5M | |
| Restructuring | $29M | $12M | $23M | $34M | $23M | $25M | $37M | $48M | $15M | $10M | · | $11M | $30M | · | $9M | |
| Other Non-cash | · | $-290M | · | · | · | $-144M | · | · | · | $21M | · | · | $-158M | · | · | |
| Operating Cash Flow | $242M | $-97M | $381M | $174M | $120M | $37M | $204M | $151M | $296M | $197M | $-32M | $231M | $27M | $254M | $98M | |
| CapEx | $30M | $25M | $43M | $33M | $32M | $31M | $36M | $34M | $37M | $41M | $39M | $40M | $31M | $29M | $24M | |
| Investing Cash Flow | $-65M | $-63M | $-147M | $-56M | $-98M | $-99M | $-58M | $-91M | $-209M | $-72M | $-327M | $-468M | $-39M | $-65M | $-152M | |
| Debt Issued | $87M | $57M | $175M | $70M | $94M | $150M | $0 | $30M | $0 | $90M | $210M | $750M | $31M | $105M | $165M | |
| Net Debt Issued | · | $18M | · | · | · | $135M | · | · | · | $30M | · | · | $30M | · | · | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Stock Repurchased | $200M | $125M | $200M | $203M | $286M | $161M | $75M | $135M | $100M | $75M | $50M | $50M | $100M | $285M | $90M | |
| Net Stock Activity | · | $-125M | · | · | · | $-161M | · | · | · | $-75M | · | · | $-100M | · | · | |
| Financing Cash Flow | $-168M | $120M | $-206M | $-127M | $56M | $89M | $-204M | $-41M | $-114M | $-151M | $394M | $248M | $21M | $-194M | $74M | |
| Net Change in Cash | $19M | $-18M | $20M | $-9M | $18M | $5M | $-4M | $-12M | $-21M | $-12M | $5M | $29M | $9M | $-6M | $15M | |
| Free Cash Flow | · | $-122M | · | · | · | $6M | · | · | · | $156M | · | · | $-4M | · | · | |
| Levered FCF | · | $-151M | · | · | · | $-21M | · | · | · | $134M | · | · | $-15M | · | · |
収益性
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.8% | 31.8% | · | 30.7% | 31.4% | 31.6% | · | 31.3% | 32.5% | 31.9% | · | 31.5% | 31.6% | · | 29.8% | |
| Operating Margin | 5.0% | 5.4% | · | 4.9% | 4.7% | 5.5% | · | 5.0% | 5.1% | 4.7% | · | 6.3% | 5.7% | · | 6.9% | |
| Net Margin | 2.7% | 3.2% | · | 3.0% | 2.6% | 3.5% | · | 3.1% | 3.3% | 2.9% | · | 4.3% | 4.0% | · | 4.9% | |
| Pretax Margin | 4.0% | 4.5% | · | 4.0% | 3.7% | 4.6% | · | 4.0% | 4.2% | 4.0% | · | 5.7% | 5.3% | · | 6.7% | |
| EBITDA Margin | 7.4% | 7.8% | · | 7.3% | 4.7% | 7.8% | · | 5.0% | 5.1% | 7.0% | · | 6.3% | 7.4% | · | 6.9% | |
| ROA | 0.84% | 0.98% | · | 0.93% | 0.81% | 1.1% | · | 0.97% | 1.1% | 0.99% | · | 1.5% | · | · | 1.8% | |
| ROE | 2.9% | 3.2% | · | 2.9% | 2.5% | 3.2% | · | 2.8% | 2.9% | 2.6% | · | 3.8% | · | · | 4.2% | |
| ROIC | 3.1% | 3.1% | · | 3.0% | 2.6% | 3.2% | · | 2.8% | 3.0% | 2.9% | · | 4.3% | · | · | 4.4% |
流動性と支払能力
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.7 | · | 2.0 | · | · | 1.8 | |
| Quick Ratio | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.7 | 0.8 | · | 0.8 | · | · | 0.7 | |
| Debt / Equity | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.1 | 0.1 | · | 0.0 | · | · | 0.0 | |
| Interest Coverage | 4.0 | 4.7 | · | 4.3 | 4.0 | 5.0 | · | 4.6 | 5.0 | 5.0 | · | 8.0 | 12.5 | · | 19.2 |
効率性
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | · | · | 0.4 | |
| Inventory Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | · | · | 1.2 | |
| Receivables Turnover | 2.0 | 2.0 | · | 2.0 | 2.0 | 2.0 | · | 2.0 | 2.1 | 2.0 | · | 2.1 | · | · | 2.0 |
1株あたり
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $28.21 | $28.54 | · | $28.35 | $28.26 | $27.08 | · | $27.99 | $27.64 | $28.02 | · | $28.10 | · | · | $26.70 | |
| Revenue / Share | $30.23 | $29.02 | · | $27.59 | $26.42 | $25.37 | · | $24.98 | $24.38 | $24.44 | · | $24.06 | $23.00 | · | $22.37 | |
| Cash Flow / Share | · | $-0.84 | · | · | · | $0.30 | · | · | · | $1.52 | · | · | $0.20 | · | · | |
| Cash / Share | $1.40 | $1.21 | · | $1.15 | $1.19 | $1.04 | · | $1.01 | $1.09 | $1.24 | · | $1.28 | · | · | · | |
| EPS (TTM) | $3.43 | $3.31 | · | $3.17 | $3.11 | $3.21 | · | $2.44 | $2.71 | $2.97 | · | $3.38 | $3.52 | · | $4.59 |
バリュエーション(TTM)
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.60B | $13.38B | · | $12.94B | $12.77B | $12.67B | · | $12.50B | $12.49B | $12.45B | · | $12.69B | $12.53B | · | $12.61B | |
| Net Income TTM | $403M | $395M | · | $391M | $389M | $407M | · | $314M | $352M | $388M | · | $445M | $478M | · | $638M | |
| Market Cap | $9.51B | $8.25B | · | $7.83B | $8.93B | $8.39B | · | $9.16B | $8.15B | $9.70B | · | $9.65B | · | · | $9.11B | |
| Enterprise Value | $10.37B | $9.16B | · | $8.61B | $9.69B | $9.13B | · | $9.68B | $8.51B | $9.81B | · | $9.49B | · | · | · | |
| P/E | 24.8 | 21.8 | · | 20.8 | 23.6 | 21.4 | · | 30.0 | 23.7 | 25.4 | · | 22.0 | 23.2 | · | 14.7 | |
| P/S | 0.7 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | · | · | 0.7 | |
| P/B | 3.0 | 2.5 | · | 2.3 | 2.6 | 2.5 | · | 2.6 | 2.3 | 2.7 | · | 2.6 | · | · | 2.5 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 85.9 | |
| P / Cash Flow | · | -85.1 | · | · | · | 226.7 | · | · | · | 49.3 | · | · | · | · | · | |
| EV / Revenue | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.7 | · | 0.8 | 0.7 | 0.8 | · | 0.7 | · | · | · | |
| Earnings Yield | 4.0% | 4.6% | · | 4.8% | 4.2% | 4.7% | · | 3.3% | 4.2% | 3.9% | · | 4.5% | 4.3% | · | 6.8% |
最新期間は左側 · null値は・として表示
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
| 指標 | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| 収益 | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B |
| 粗利益率 % | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% |
| 営業利益率 % | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% |
| 純利益 | $398M | $390M | $416M | $538M | $631M |
| 希薄化後EPS | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 |
| 指標 | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| 負債資本倍率 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
| 流動比率 | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 |
| クイックレシオ | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 |
| 指標 | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| フリーキャッシュフロー | $573M | $700M | $353M | $506M | $631M |
機関投資家(13F) 600 提出者 · $11.2B合計 · 時点 2026年9月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 64 (-16 前期比) | 60 (+14 前期比) | 173 (-3 前期比) | 220 (+25 前期比) | +9.1M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | $1,307,257,713 | 15,652,032 | 11.68% | 株式数 |
| VANGUARD GROUP INC | $875,836,080 | 11,588,199 | 7.82% | 株式数 |
| FMR LLC | $630,901,802 | 7,553,901 | 5.64% | 株式数 |
| BlackRock, Inc. | $586,699,894 | 7,024,663 | 5.24% | 株式数 |
| Artisan Partners Limited Partnership | $540,162,844 | 6,467,467 | 4.82% | 株式数 |
| VANGUARD CAPITAL MANAGEMENT LLC | $530,073,795 | 6,346,669 | 4.73% | 株式数 |
| JPMORGAN CHASE & CO | $366,432,667 | 4,342,929 | 3.27% | 株式数 |
| STATE STREET CORP | $359,576,652 | 4,305,276 | 3.21% | 株式数 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $345,225,076 | 4,133,442 | 3.08% | 株式数 |
| AMERICAN CENTURY COMPANIES INC | $288,743,396 | 3,457,175 | 2.58% | 株式数 |
| DIMENSIONAL FUND ADVISORS LP | $283,495,786 | 3,394,242 | 2.53% | 株式数 |
| Southpoint Capital Advisors LP | $275,616,000 | 3,300,000 | 2.46% | 株式数 |
| Invesco Ltd. | $263,107,794 | 3,150,237 | 2.35% | 株式数 |
| CITADEL ADVISORS LLC | $243,970,523 | 2,921,103 | 2.18% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $227,537,373 | 2,729,030 | 2.03% | 株式数 |
| Palestra Capital Management LLC | $204,347,632 | 2,446,691 | 1.83% | 株式数 |
| BANK OF MONTREAL /CAN/ | $176,687,394 | 2,115,510 | 1.58% | 株式数 |
| MORGAN STANLEY | $175,460,572 | 2,100,819 | 1.57% | 株式数 |
| FIDUCIARY MANAGEMENT INC /WI/ | $151,785,323 | 1,817,353 | 1.36% | 株式数 |
| Burgundy Asset Management Ltd. | $151,049,204 | 2,170,871 | 1.35% | 株式数 |
| LYRICAL ASSET MANAGEMENT LP | $122,553,156 | 1,467,351 | 1.09% | 株式数 |
| UBS Group AG | $111,653,127 | 1,336,843 | 1.00% | 株式数 |
| Swedbank AB | $109,479,854 | 1,310,822 | 0.98% | 株式数 |
| M.D. Sass, LLC | $107,485,396 | 1,286,942 | 0.96% | 株式数 |
| SNYDER CAPITAL MANAGEMENT L P | $107,341,992 | 1,285,225 | 0.96% | 株式数 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $107,262,144 | 1,272,537 | 0.96% | 株式数 |
| NORGES BANK | $103,383,729 | 1,237,832 | 0.92% | 株式数 |
| BANK OF AMERICA CORP /DE/ | $101,266,079 | 1,212,477 | 0.90% | 株式数 |
| GOLDMAN SACHS GROUP INC | $98,070,544 | 1,174,216 | 0.88% | 株式数 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $86,593,118 | 1,036,795 | 0.77% | 株式数 |
| NORTHERN TRUST CORP | $80,548,694 | 964,424 | 0.72% | 株式数 |
| NOMURA HOLDINGS INC | $77,065,658 | 922,721 | 0.69% | 株式数 |
| PZENA INVESTMENT MANAGEMENT LLC | $71,888,420 | 860,733 | 0.64% | 株式数 |
| DME Capital Management, LP | $60,013,296 | 718,550 | 0.54% | 株式数 |
| Ananym Capital Management, LP | $57,978,164 | 694,183 | 0.52% | 株式数 |
| Ulysses Management LLC | $55,570,700 | 665,358 | 0.50% | 株式数 |
| STALEY CAPITAL ADVISERS INC | $55,252,489 | 661,548 | 0.49% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $45,489,502 | 544,654 | 0.41% | 株式数 |
| RAYMOND JAMES FINANCIAL INC | $42,948,907 | 514,235 | 0.38% | 株式数 |
| Bank of New York Mellon Corp | $42,261,071 | 505,999 | 0.38% | 株式数 |
| Nuveen, LLC | $38,262,099 | 458,119 | 0.34% | 株式数 |
| DEUTSCHE BANK AG\ | $36,574,075 | 437,908 | 0.33% | 株式数 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $35,970,895 | 430,686 | 0.32% | 株式数 |
| Clarkston Capital Partners, LLC | $35,168,100 | 421,074 | 0.31% | 株式数 |
| LONE PEAK GLOBAL INVESTORS LLC | $33,404,158 | 399,954 | 0.30% | 株式数 |
| GAMCO INVESTORS, INC. ET AL | $30,537,668 | 365,633 | 0.27% | 株式数 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $27,342,332 | 370,995 | 0.24% | 株式数 |
| PRIVATE MANAGEMENT GROUP INC | $27,285,483 | 326,694 | 0.24% | 株式数 |
| FRANKLIN RESOURCES INC | $25,575,244 | 306,217 | 0.23% | 株式数 |
| BNP PARIBAS FINANCIAL MARKETS | $25,194,142 | 301,654 | 0.23% | 株式数 |
アクティビストおよび5%超のオーナー 2保有
SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図(アクティビストの保有、取締役会キャンペーン、M&A)を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。
| 提出者 | 提出済み | 保有 | ステータス | 目的 | 提出書類 |
|---|---|---|---|---|---|
| KKR Hawaii Holdings L.P., KKR Hawaii Holdings GP LLC, KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 提出書類 | 2026年3月10日 | 16.40% | 修正 | · | SEC |
| KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 提出書類 | 2025年8月8日 | 13.00% | 修正 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
企業インサイダー 52 人のインサイダー · 25人の役員 · 22人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| Andrea Albertini | CEO, Global Dist. & Tech. | 2026年9月8日 D | 116,104 | 0 | 0 | $0 |
| Thomas C Popeck | CEO, Henry Schein Products | 2026年3月19日 S | 86,182 | 0 | 1 | $-98,630 |
| Frederick M. Lowery | CEO | 2026年3月6日 A | 95,156 | 0 | 0 | $0 |
| Bradford C Connett | CEO, NA Distribution Group | 2025年3月19日 S | 62,688 | 0 | 0 | $0 |
| David B Brous Jr | CEO, Strategic Business Group | 2023年6月12日 S | 68,690 | 0 | 0 | $0 |
| Karen Prange | EVP&CEO Gl.AH.Med.Den.Sur.Grp | 2018年3月2日 A | 62,902 | 0 | 0 | $0 |
| Lonnie Shoff | CEO, Global Strat Port Grp | 2016年3月15日 S | 31,000 | 0 | 0 | $0 |
| Ronald N. South | SVP & Chief Financial Officer | 2026年3月16日 F | 88,930 | 0 | 0 | $0 |
| James P Breslawski | President | 2025年3月14日 D | 200,227 | 0 | 0 | $0 |
| Bridget A Ross | President, Global Medical Grp | 2017年3月6日 A | 9,654 | 0 | 0 | $0 |
| Michael Zack | President of Int'l Group | 2013年3月7日 M | 48,716 | 0 | 0 | $0 |
| Michael S Ettinger | EVP & Chief Operating Officer | 2026年3月17日 G | 112,208 | 0 | 0 | $0 |
| Christine Zayac Sheehy | SVP, Chief Human Res. Officer | 2026年3月16日 F | 18,454 | 0 | 0 | $0 |
| Mark E Mlotek | EVP, Chief Strategic Officer | 2026年3月16日 F | 98,372 | 0 | 2 | $-478,758 |
| Walter Siegel | Sr. VP & Chief Legal Officer | 2025年3月14日 D | 43,191 | 0 | 0 | $0 |
| Lorelei Mcglynn | SVP, Chief Human Res. Officer | 2024年9月6日 S | 71,833 | 0 | 0 | $0 |
| Gerald A Benjamin | EVP, Chief Admin. Officer | 2022年5月26日 S | 95,616 | 0 | 0 | $0 |
| David Mckinley | CCO&Pres. Corp. Com. Dev. Grp. | 2018年11月30日 S | 68,012 | 0 | 0 | $0 |
| Paul Rose | SVP, Global Supply Chain | 2017年9月6日 S | 17,841 | 0 | 0 | $0 |
| Robert Minowitz | Pres., Int'l Dental Group EMEA | 2017年5月12日 S | 22,943 | 0 | 0 | $0 |
| Michael Racioppi | SVP Chief Merchandising Offic. | 2017年3月20日 M | 23,088 | 0 | 0 | $0 |
| Peter M. Mccarthy | Pres., Global Animal Health | 2017年3月13日 S | 14,277 | 0 | 0 | $0 |
| James A. Harding | SVP, Chief Technology Officer | 2017年3月8日 S | 16,589 | 0 | 0 | $0 |
| Stanley Komaroff | Senior Advisor | 2016年3月2日 F | 25,144 | 0 | 0 | $0 |
| Leonard A David | SVP, Chief Compliance Officer | 2015年3月17日 S | 12,343 | 0 | 0 | $0 |
| William K Daniel | 取締役 | 2026年6月12日 A | 7,641 | 1 | 0 | $691,900 |
| Scott Philip Serota | 取締役 | 2026年3月6日 A | 10,790 | 0 | 0 | $0 |
| Carole T Faig | 取締役 | 2026年3月6日 A | 8,025 | 0 | 0 | $0 |
| Anne H. Margulies | 取締役 | 2026年3月6日 A | 23,153 | 0 | 0 | $0 |
| Mohamad Ali | 取締役 | 2026年3月6日 A | 15,075 | 0 | 0 | $0 |
| Reed Vaughn Tuckson | 取締役 | 2026年3月6日 A | 12,520 | 0 | 0 | $0 |
| Robert J. Hombach | 取締役 | 2026年3月6日 A | 5,421 | 0 | 0 | $0 |
| Bradley T Sheares | 取締役 | 2026年3月6日 A | 47,623 | 0 | 0 | $0 |
| Philip A Laskawy | 取締役 | 2026年3月6日 A | 24,538 | 0 | 1 | $-228,544 |
| Carol Raphael | 取締役 | 2025年5月21日 F | 33,538 | 0 | 0 | $0 |
| Steven Paladino | 取締役 | 2024年3月4日 A | 138,272 | 0 | 0 | $0 |
| Dianne E Rekow | 取締役 | 2022年3月16日 A | 18,526 | 0 | 0 | $0 |
| Barry J Alperin | 取締役 | 2022年3月16日 A | 52,473 | 0 | 0 | $0 |
| Paul Brons | 取締役 | 2021年3月3日 F | 16,854 | 0 | 0 | $0 |
| Shira Goodman | 取締役 | 2021年3月3日 A | 5,689 | 0 | 0 | $0 |
| Lawrence S Bacow | 取締役 | 2018年3月6日 F | 10,115 | 0 | 0 | $0 |
| Donald J Kabat | 取締役 | 2018年3月6日 F | 10,874 | 0 | 0 | $0 |
| Louis W Sullivan | 取締役 | 2016年3月31日 A | 14,096 | 0 | 0 | $0 |
| Norman S Matthews | 取締役 | 2016年3月31日 A | 12,890 | 0 | 0 | $0 |
| Karyn Mashima | 取締役 | 2014年3月10日 F | 19,269 | 0 | 0 | $0 |
| Irving Shafran | 取締役 | 2003年11月20日 S | 750,000 | 0 | 0 | $0 |
| Stanley M Bergman | · | 2026年5月26日 G | 253,279 | 0 | 5 | $-7,544,687 |
| Kurt P Kuehn | · | 2026年3月10日 S | 15,420 | 0 | 1 | $-224,562 |
| Deborah Derby | · | 2026年3月6日 A | 15,093 | 0 | 0 | $0 |
| Joseph L Herring | · | 2026年3月6日 A | 30,325 | 0 | 0 | $0 |
| Margaret A Hamburg | · | 2009年5月20日 M | 0 | 0 | 0 | $0 |
| Pamela Joseph | · | 2004年11月16日 S | 98,879 | 0 | 0 | $0 |
SECフォーム3/4/5提出書類からのインサイダー;純額=公開市場のP/Sのみ
ETF保有状況 86のETFが保有
ウェイトは直接株式保有(N-PORT)のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| RSPH · Invesco Exchange-Traded Fund Trust | 1.59% | 163,520 SH | 2026年10月2日 | 日次 |
| GURU · Global X Funds | 1.29% | 9,179 NS | 2026年7月31日 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0.87% | 106,077 NS | 2026年7月31日 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0.65% | 126,921 SH | 2026年10月2日 | 日次 |
| FBCV · FIDELITY COVINGTON TRUST | 0.36% | 7,509 NS | 2026年7月31日 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.33% | 18,150 NS | 2026年7月31日 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0.33% | 12,855 NS | 2026年7月31日 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0.28% | 54,697 SH | 2026年10月2日 | 日次 |
| BKMC · BNY Mellon ETF Trust | 0.23% | 17,140 NS | 2026年7月31日 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.22% | 364,767 NS | 2026年7月31日 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0.20% | 2,218,557 SH | 2026年10月2日 | 日次 |
| FSMD · FIDELITY COVINGTON TRUST | 0.20% | 57,583 NS | 2026年7月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.19% | 343,006 NS | 2026年7月31日 | N-PORT |
| ESML · iShares Trust | 0.18% | 58,607 SH | 2026年9月11日 | 日次 |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.17% | 41,019 NS | 2026年7月31日 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.17% | 1,416,056 SH | 2026年8月19日 | 日次 |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.15% | 24,666 NS | 2026年7月31日 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0.15% | 3,879 NS | 2026年7月31日 | N-PORT |
| IYH · iShares Trust | 0.14% | 57,526 SH | 2026年9月11日 | 日次 |
| NUSC · Nushares ETF Trust | 0.14% | 20,654 NS | 2026年7月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.12% | 46,652 NS | 2026年7月31日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.12% | 293,098 SH | 2026年8月19日 | 日次 |
| SMMD · iShares Trust | 0.12% | 52,697 SH | 2026年9月11日 | 日次 |
| IXJ · iShares Trust | 0.11% | 51,636 SH | 2026年9月11日 | 日次 |
| VB · VANGUARD INDEX FUNDS | 0.10% | 2,230,411 SH | 2026年8月19日 | 日次 |
| CURE · Direxion Shares ETF Trust | 0.10% | 1,905 NS | 2026年7月31日 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.09% | 8,660 SH | 2026年10月2日 | 日次 |
| VFMF · VANGUARD WELLINGTON FUND | 0.09% | 7,550 SH | 2026年8月19日 | 日次 |
| IWS · iShares Trust | 0.08% | 146,411 SH | 2026年9月10日 | 日次 |
| TILT · FlexShares Trust | 0.08% | 20,224 NS | 2026年7月31日 | N-PORT |
| WSML · iShares Trust | 0.08% | 6,020 SH | 2026年9月11日 | 日次 |
| VFVA · VANGUARD WELLINGTON FUND | 0.07% | 7,214 SH | 2026年8月19日 | 日次 |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.07% | 77,119 SH | 2026年10月2日 | 日次 |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0.07% | 6,494 NS | 2026年7月31日 | N-PORT |
| IWR · iShares Trust | 0.06% | 403,437 SH | 2026年9月11日 | 日次 |
| DFUV · Dimensional ETF Trust | 0.06% | 98,929 NS | 2026年7月31日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.05% | 13,423 NS | 2026年7月31日 | N-PORT |
| XOEF · iShares Trust | 0.05% | 125 SH | 2026年9月11日 | 日次 |
| DFAC · Dimensional ETF Trust | 0.05% | 270,764 NS | 2026年7月31日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.05% | 2,999 NS | 2026年7月31日 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.04% | 5,048 SH | 2026年10月2日 | 日次 |
| FAB · First Trust Exchange-Traded AlphaDE… | 0.04% | 858 NS | 2026年7月31日 | N-PORT |
| CATH · Global X Funds | 0.04% | 6,000 NS | 2026年7月31日 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0.04% | 44,360 SH | 2026年10月2日 | 日次 |
| DCOR · Dimensional ETF Trust | 0.03% | 13,104 NS | 2026年7月31日 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.03% | 22,387 SH | 2026年8月19日 | 日次 |
| IVE · iShares Trust | 0.03% | 160,669 SH | 2026年9月11日 | 日次 |
| IUSV · iShares Trust | 0.03% | 83,684 SH | 2026年9月11日 | 日次 |
| CHRI · Global X Funds | 0.03% | 24 NS | 2026年7月31日 | N-PORT |
| DSI · iShares Trust | 0.02% | 14,799 SH | 2026年9月10日 | 日次 |
| IWD · iShares Trust | 0.02% | 218,760 SH | 2026年9月11日 | 日次 |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 59,466 SH | 2026年8月19日 | 日次 |
| EGLE · Global X Funds | 0.02% | 5 NS | 2026年7月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.02% | 25,929 NS | 2026年7月31日 | N-PORT |
| XYLG · Global X Funds | 0.02% | 132 NS | 2026年7月31日 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.02% | 3,116 SH | 2026年10月2日 | 日次 |
| TOPC · iShares Trust | 0.02% | 59 SH | 2026年9月10日 | 日次 |
| XCLR · Global X Funds | 0.01% | 6 NS | 2026年7月31日 | N-PORT |
| XVV · iShares Trust | 0.01% | 1,104 SH | 2026年9月11日 | 日次 |
| PTLC · Pacer Funds Trust | 0.01% | 5,070 NS | 2026年7月31日 | N-PORT |
| IVV · iShares Trust | 0.01% | 1,220,662 SH | 2026年9月11日 | 日次 |
| XYLD · Global X Funds | 0.01% | 4,788 NS | 2026年7月31日 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0.01% | 576 SH | 2026年10月2日 | 日次 |
| DFUS · Dimensional ETF Trust | 0.01% | 30,222 NS | 2026年7月31日 | N-PORT |
| IWB · iShares Trust | 0.01% | 68,043 SH | 2026年9月11日 | 日次 |
| XRMI · Global X Funds | 0.01% | 70 NS | 2026年7月31日 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0.01% | 365 NS | 2026年7月31日 | N-PORT |
| IWV · iShares Trust | 0.01% | 27,083 SH | 2026年9月9日 | 日次 |
| IYY · iShares Trust | 0.01% | 4,036 SH | 2026年9月10日 | 日次 |
| QDPL · Pacer Funds Trust | 0.01% | 2,304 NS | 2026年7月31日 | N-PORT |
| ITOT · iShares Trust | 0.01% | 123,729 SH | 2026年9月11日 | 日次 |
| PHDG · Invesco Actively Managed Exchange-T… | 0.01% | 77 SH | 2026年10月2日 | 日次 |
| HCMT · Direxion Shares ETF Trust | 0.01% | 674 NS | 2026年7月31日 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0.01% | 2,513,394 SH | 2026年8月19日 | 日次 |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 3,089,160 SH | 2026年8月19日 | 日次 |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 81,658 SH | 2026年8月19日 | 日次 |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.01% | 16,261 SH | 2026年8月19日 | 日次 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 8,309 SH | 2026年8月19日 | 日次 |
| ESGV · VANGUARD WORLD FUND | 0.01% | 22,281 SH | 2026年8月19日 | 日次 |
| SPXL · Direxion Shares ETF Trust | 0.01% | 7,569 NS | 2026年7月31日 | N-PORT |
| XTR · Global X Funds | 0.01% | 4 NS | 2026年7月31日 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.00% | 99 NS | 2026年7月31日 | N-PORT |
| ISCB · iShares Trust | · | 4,208 SH | 2026年9月11日 | 日次 |
| ISCV · iShares Trust | · | 20,757 SH | 2026年9月11日 | 日次 |
| SMLF · iShares Trust | · | 8,316 SH | 2026年9月11日 | 日次 |
| SMMV · iShares Trust | · | 19,508 SH | 2026年8月19日 | 日次 |
HSIC アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
12ヶ月目標株価
15 アナリスト · 2026-09-30平均値ターゲット $97.27 +15.5%
同業他社比較(GICSサブインダストリー) 主要メトリクスとセクターピアの比較
FY基準、価格は各社の直近年度末終値。
最新ニュース この会社に言及した最近の見出し
トレードシグナル エントリー価格とリスク/リワード比率を伴う最近の売買シグナル
現在オープンシグナルはありません — カードは塗りつぶされておらず、それが正直なところです。
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
重視する指標を選択してください — 上記の「財務諸表」の任意の行の横にある「+」をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。